Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001725094-18-000001
Filing Date
2018-01-10
Accepted
2018-01-10 14:00:48
Documents
1
Effectiveness Date
2018-01-10
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 8844
  Complete submission text file 0001725094-18-000001.txt   9897
Mailing Address 219 TERRY AVE. N. SUITE 300 SEATTLE WA 98092
Business Address 219 TERRY AVE. N. SUITE 300 SEATTLE WA 98092 2063780400
Kv1.3 Therapeutics, Inc. (Filer) CIK: 0001725094 (see all company filings)

EIN.: 823583426 | State of Incorp.: WA | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-302850 | Film No.: 18521138